June 2013
Volume 54, Issue 15
ARVO Annual Meeting Abstract  |   June 2013
Characterization of the Gene Expression Profile of Conjunctivochalasis
Author Affiliations & Notes
  • Stella Paparizos
    Ophthalmology, Summa Health System, Akron, OH
  • Rachida Bouhenni
    Ophthalmology, Summa Health System, Akron, OH
  • Jeffrey Dunmire
    Ophthalmology, Summa Health System, Akron, OH
  • Todd Beyer
    Ophthalmology, Summa Health System, Akron, OH
  • Khaled Abu-Amero
    Ophthalmology, King Saud University, Riyadh, Saudi Arabia
  • Deepak Edward
    Ophthalmology, King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia
    Ophthalmology, Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD
  • Footnotes
    Commercial Relationships Stella Paparizos, None; Rachida Bouhenni, None; Jeffrey Dunmire, None; Todd Beyer, None; Khaled Abu-Amero, None; Deepak Edward, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 2124. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Stella Paparizos, Rachida Bouhenni, Jeffrey Dunmire, Todd Beyer, Khaled Abu-Amero, Deepak Edward; Characterization of the Gene Expression Profile of Conjunctivochalasis. Invest. Ophthalmol. Vis. Sci. 2013;54(15):2124.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: The pathogenesis of conjunctivochalasis remains unclear. We hypothesized that gene expression profiling of conjunctival tissue from patients with conjunctivochalasis would give us an insight into the molecular pathways involved in its pathogenesis. To test this hypothesis we studied differential gene expression of conjunctivochalasis tissue compared to age-matched control conjunctival tissue with no history of ocular disease.

Methods: Surgical specimens of conjunctivochalasis (n=4) and age-matched control conjunctival tissue (n=4) were obtained for comparison during conjunctivoplasty or strabismus surgery, respectively. Whole genome expression profiling using the Agilent human genome array slide 4x44K was performed on total RNA extracts. Differential gene expression was analyzed using GeneSpring GX 12. Genes with ≥2 fold increased or decreased expression across all four conjunctivochalasis samples were selected for further analyses. Gene ontology was determined using the PANTHER (Protein Analysis Through Evolutionary Relationships) analysis software.

Results: A total of 1021 genes were found to be over-expressed, and 1046 genes were found to be under-expressed in all four conjunctivochalasis specimens compared to age-matched controls after excluding pseudo genes, cDNA transcripts without coded proteins, predicted proteins based on sequence homology, and genes with hypothetical or uncharacterized proteins. The protein products of the altered (over and under-expressed) genes are involved in multiple signaling pathways and biological functions including: angiogenesis; apoptosis; chemokine/cytokine-mediated inflammation; P53 signaling; and Alzheimer’s/prensilin.

Conclusions: The gene expression profile of the conjunctivochalasis phenotype is complex. The up- and down-regulation of genes from the same pathways suggests that angiogenesis, chemokine/cytokine-mediated inflammation and apoptosis, through P53 regulation, could be important in the pathogenesis of conjunctivochalasis.

Keywords: 474 conjunctiva • 533 gene/expression  

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.